2017-03-24,Xenon Pharmaceuticals Becomes Oversold (XENE)
2017-03-24,Xenon Pharmaceuticals Announces XEN801 Did Not Meet Efficacy Endpoints In Phase 2 Clinical Trial In Patients With Moderate To Severe Acne
2017-03-08,Xenon Pharmaceuticals Reports 2016 Financial Results And Provides Corporate Update
2017-03-01,Xenon Pharmaceuticals To Host Conference Call And Webcast To Discuss 2016 Financial Results And Provide Corporate Update
2017-01-08,Xenon Pharmaceuticals Outlines Key Milestones For 2017
2016-11-08,Xenon Pharmaceuticals To Present At The Stifel 2016 Healthcare Conference
2016-11-03,Xenon Pharmaceuticals Reports Third Quarter 2016 Financial Results And Provides Corporate Update
2016-10-27,Xenon Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2016 Financial Results And Provide Corporate Update
2016-09-27,Xenon Pharmaceuticals Appoints Dawn Svoronos To Its Board Of Directors
2016-09-13,Xenon Pharmaceuticals Announces Exercise In Full Of Option To Purchase Additional Shares And Closing Of $34.5 Million Public Offering
2016-09-08,Xenon Pharmaceuticals Announces Pricing Of $30 Million Public Offering Of Common Shares
2016-09-07,Xenon Pharmaceuticals Announces Proposed Public Offering Of Common Shares
2016-08-03,Xenon Pharmaceuticals Reports Second Quarter 2016 Financial Results And Provides Corporate Update
2016-08-02,Xenon Pharmaceuticals To Present At The Canaccord Genuity 36th Annual Growth Conference
2016-07-25,Xenon Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2016 Financial Results And Provide Corporate Update
2016-06-08,Xenon Pharmaceuticals Presents Corporate Update And Highlights Its Proprietary Therapeutic Programs At The Jefferies 2016 Healthcare Conference
2016-06-02,Xenon Pharmaceuticals To Present At The Jefferies 2016 Healthcare Conference
2016-05-10,Xenon Pharmaceuticals Reports First Quarter 2016 Financial Results And Provides Corporate Update
2016-05-02,Xenon Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2016 Financial Results And Provide Corporate Update
2016-04-04,Xenon Names Dr. Raymond J. Winquist As Head, Translational Research
2016-03-31,Xenon Pharmaceuticals To Provide Business And Milestone Update At Needham Healthcare Conference
2016-03-15,Xenon And Genentech Extend Collaborations Focused On Pain
2016-03-08,Xenon Pharmaceuticals Reports 2015 Financial Results And Provides Corporate Update
2016-03-01,Xenon Pharmaceuticals To Host Conference Call And Webcast To Discuss 2015 Financial Results And Provide Corporate Update
2016-02-10,Xenon Initiates Phase 2 Clinical Trial Of XEN801 To Treat Moderate To Severe Acne
2016-02-09,Xenon Names Dr. James R. Empfield Senior Vice President, Drug Discovery
2016-01-11,Xenon Outlines Key Milestones For 2016
2015-12-17,Xenon And Genentech Publish In Science The 3-D Crystal Structure Of A Novel Nav1.7 Compound Binding Site Enabling The Development Of Potent Selective Inhibitors To Treat Pain
2015-12-08,Ratings Changes Today
2015-11-12,Xenon Pharmaceuticals To Present At The Stifel 2015 Healthcare Conference
2015-11-10,Xenon Pharmaceuticals Reports Third Quarter 2015 Financial Results And Provides Corporate Update
2015-11-05,Xenon Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2015 Financial Results And Provide Corporate Update
2015-10-22,Xenon Announces Its Partner Genentech Has Advanced GDC-0310, A Second Nav1.7 Inhibitor For Pain, Into Clinical Development
2015-09-24,Xenon Pharmaceuticals Announces Initiation Of XEN801 Phase 1 Clinical Trial
2015-09-21,Xenon Pharmaceuticals Achieves Milestone In Genentech Collaboration To Discover Novel Pain Targets
2015-09-03,Xenon Pharmaceuticals To Present At The 10th Annual Wells Fargo Healthcare Conference
2015-08-10,Xenon Pharmaceuticals Reports Second Quarter 2015 Financial Results And Provides Corporate Update
2015-08-07,Xenon Pharmaceuticals is Now Oversold (XENE)
2015-08-06,Xenon Pharmaceuticals To Present At The Canaccord Genuity 35th Annual Growth Conference
2015-08-05,Xenon Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2015 Financial Results And Provide Corporate Update
2015-07-08,9 Investments Wilbur Ross Is Making That Aren't Greece
2015-07-01,Xenon Pharmaceuticals To Host Conference Call And Webcast Today At 9:00 A.m. Eastern Time To Discuss TV-45070 Phase 2b Study In Osteoarthritis Pain
2015-07-01,Teva And Xenon Provide Update On TV-45070 Phase 2b Study In Osteoarthritis Pain
2015-07-01,Teva And Xenon Provide Update On TV-45070 Phase 2b Study In Osteoarthritis Pain
2015-05-28,Xenon Pharmaceuticals To Provide Business And Milestone Update At Jefferies 2015 Global Healthcare Conference
2015-05-22,Xenon Pharmaceuticals Appoints Steven Gannon To Its Board Of Directors
2015-05-20,Relative Strength Alert For Xenon Pharmaceuticals
2015-05-12,Xenon Pharmaceuticals Reports First Quarter 2015 Financial Results And Provides Corporate Update
2015-05-07,Xenon Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2015 Financial Results And Provide Corporate Update
2015-04-21,Oversold Conditions For Xenon Pharmaceuticals (XENE)
2015-04-02,Voltari Corp. Dips After Icahn-Driven Surge
2015-04-02,Teva And Xenon Announce Enrollment Of First Patient In A Phase 2b Study Evaluating TV-45070 For Postherpetic Neuralgia (PHN)
2015-03-16,Xenon Pharmaceuticals Appoints Dr. Richard H. Scheller To Its Board Of Directors
2015-03-12,Xenon Pharmaceuticals Reports 2014 Financial Results And Provides Corporate Update
2015-03-09,Xenon Pharmaceuticals To Host Conference Call And Webcast To Discuss 2014 Financial Results And Provide Corporate Update
2015-02-23,15 Biggest Buys Buffett, Icahn and Other Big Investors Made Last Quarter
2015-02-20,4 Stocks Spiking on Big Volume: Xenon, Opus Bank and More
2015-02-19,Xenon Pharmaceuticals' Partner Teva To Initiate Phase 2b Clinical Trial Of TV-45070 In Post-Herpetic Neuralgia
2015-01-08,Xenon Pharmaceuticals Outlines Key Anticipated Milestones For 2015
2014-12-29,Market News: Manitowoc, Xenon Pharmaceuticals, USMD Holdings
2014-12-15,Xenon Pharmaceuticals Reports Third Quarter 2014 Financial Results
2014-11-04,Xenon Pharmaceuticals Announces Pricing Of Initial Public Offering
,
,
,
